We are advised by Jiangsu Vcare that journalists and other readers should disregard the news release, Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA, issued 04-Jan-2024 over PR Newswire.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Bybit CEO Ben Zhou Meets Georgian Prime Minister, Reinforcing Commitment to Compliance-Led Growth and Local Collaboration

DUBAI, UAE, March 17, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange…

"Digital Entertainment Leadership Forum 2026" Concludes Three-Day Run with Over 4,000 Participants Exploring …

HONG KONG SAR – Media OutReach Newswire – 30 August 2026 –…

ChatBar AI and Anam Partner to Launch Human-Real AI Personas

A New Standard for Shareable AI Interaction SINGAPORE, Dec. 2, 2025 /PRNewswire/…